These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 28950396)

  • 21. Morphometric brain characterization of refractory obsessive-compulsive disorder: diffeomorphic anatomic registration using exponentiated Lie algebra.
    Tang W; Li B; Huang X; Jiang X; Li F; Wang L; Chen T; Wang J; Gong Q; Yang Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():126-31. PubMed ID: 23876787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The glutamate-based genetic immune hypothesis in obsessive-compulsive disorder. An integrative approach from genes to symptoms.
    Rotge JY; Aouizerate B; Tignol J; Bioulac B; Burbaud P; Guehl D
    Neuroscience; 2010 Jan; 165(2):408-17. PubMed ID: 19861150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential efficacy of memantine for obsessive-compulsive disorder vs. generalized anxiety disorder: an open-label trial.
    Feusner JD; Kerwin L; Saxena S; Bystritsky A
    Psychopharmacol Bull; 2009; 42(1):81-93. PubMed ID: 19204653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obsessive compulsive behaviour in autism--towards an autistic-obsessive compulsive syndrome?
    Gross-Isseroff R; Hermesh H; Weizman A
    World J Biol Psychiatry; 2001 Oct; 2(4):193-7. PubMed ID: 12587149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered serotonergic and GABAergic neurotransmission in a mice model of obsessive-compulsive disorder.
    Winter C; Greene DM; Mavrogiorgou P; Schaper H; Sohr R; Bult-Ito A; Juckel G
    Behav Brain Res; 2018 Jan; 337():240-245. PubMed ID: 28916503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Topiramate augmentation in treatment-resistant obsessive-compulsive disorder].
    Vinkers DJ; van der Wee NJ
    Tijdschr Psychiatr; 2008; 50(11):747-50. PubMed ID: 18991236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of glutamate in striatal subregions in obsessive-compulsive disorder with proton magnetic resonance spectroscopy.
    Simpson HB; Kegeles LS; Hunter L; Mao X; Van Meter P; Xu X; Kimeldorf MB; Pearlstein SL; Slifstein M; Shungu DC
    Psychiatry Res; 2015 Apr; 232(1):65-70. PubMed ID: 25715904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current and emerging features of obsessive-compulsive disorder--trends for the revision of DSM-5].
    Matsunaga H
    Seishin Shinkeigaku Zasshi; 2012; 114(9):1023-30. PubMed ID: 23198591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment.
    Pittenger C; Bloch MH; Williams K
    Pharmacol Ther; 2011 Dec; 132(3):314-32. PubMed ID: 21963369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic inositol increases striatal D(2) receptors but does not modify dexamphetamine-induced motor behavior. Relevance to obsessive-compulsive disorder.
    Harvey BH; Scheepers A; Brand L; Stein DJ
    Pharmacol Biochem Behav; 2001 Feb; 68(2):245-53. PubMed ID: 11267629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Obsessive-compulsive disorder associated with brain lesions: clinical phenomenology, cognitive function, and anatomic correlates.
    Berthier ML; Kulisevsky J; Gironell A; Heras JA
    Neurology; 1996 Aug; 47(2):353-61. PubMed ID: 8757004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of gender and executive function on visuospatial working memory in adult obsessive-compulsive disorder.
    Martoni RM; Salgari G; Galimberti E; Cavallini MC; O'Neill J
    Eur Arch Psychiatry Clin Neurosci; 2015 Dec; 265(8):707-18. PubMed ID: 25972085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Olfactory identification deficits and associated response inhibition in obsessive-compulsive disorder: on the scent of the orbitofronto-striatal model.
    Bersani G; Quartini A; Ratti F; Pagliuca G; Gallo A
    Psychiatry Res; 2013 Nov; 210(1):208-14. PubMed ID: 23870490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased memory confidence in obsessive-compulsive disorder for scenarios high and low on responsibility: is low still too high?
    Moritz S; Jaeger A
    Eur Arch Psychiatry Clin Neurosci; 2018 Apr; 268(3):291-299. PubMed ID: 28353028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OCD-like behavior is caused by dysfunction of thalamo-amygdala circuits and upregulated TrkB/ERK-MAPK signaling as a result of SPRED2 deficiency.
    Ullrich M; Weber M; Post AM; Popp S; Grein J; Zechner M; Guerrero González H; Kreis A; Schmitt AG; Üçeyler N; Lesch KP; Schuh K
    Mol Psychiatry; 2018 Feb; 23(2):444-458. PubMed ID: 28070119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic findings in obsessive-compulsive disorder connect to brain-derived neutrophic factor and mammalian target of rapamycin pathways: implications for drug development.
    Grados M; Sung HM; Kim S; Srivastava S
    Drug Dev Res; 2014 Sep; 75(6):372-83. PubMed ID: 25195581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.
    Korff S; Harvey BH
    Psychiatr Clin North Am; 2006 Jun; 29(2):371-90. PubMed ID: 16650714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obsessive-compulsive disorder: an integrative genetic and neurobiological perspective.
    Pauls DL; Abramovitch A; Rauch SL; Geller DA
    Nat Rev Neurosci; 2014 Jun; 15(6):410-24. PubMed ID: 24840803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative neuropsychology of adult obsessive-compulsive disorder and attention deficit/hyperactivity disorder: implications for a novel executive overload model of OCD.
    Abramovitch A; Dar R; Hermesh H; Schweiger A
    J Neuropsychol; 2012 Sep; 6(2):161-91. PubMed ID: 22257360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fronto-striatal glutamatergic compounds in compulsive and impulsive syndromes: a review of magnetic resonance spectroscopy studies.
    Naaijen J; Lythgoe DJ; Amiri H; Buitelaar JK; Glennon JC
    Neurosci Biobehav Rev; 2015 May; 52():74-88. PubMed ID: 25712432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.